November 7, 2015Open Access
Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid
Key Points
Key points are not available for this paper at this time.
Abstract
The Elecsys β-amyloid (1-42) assay has high analytical performance that may improve biomarker-based AD diagnosis.